Concurrent use of opioids and benzodiazepines/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study
Main Author: | Ed Jess |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/11/e038692.full |
Similar Items
-
A Population-Based Examination of Benzodiazepine Receptor Agonist & Z-drug Dispensations in the Alberta Population: Prevalence of Use and Indicators of Potentially Inappropriate Use and Prescribing
by: Daniala Weir, et al.
Published: (2018-09-01) -
Benzodiazepine prescribing patterns and drug overdose deaths among individuals receiving opioid analgesics
by: Park, Tae Woo
Published: (2016) -
The risk factors for concurrent use of benzodiazepines or death among non-cancer patients with long-term opioid analgesics use
by: Po-FengLee, et al.
Published: (2019) -
Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada
by: Cerina Lee, et al.
Published: (2021-05-01) -
At-a-glance - Concurrent monitoring of opioid prescribing practices and opioid-related deaths: the context in Nova Scotia, Canada
by: Emily Schleihauf, et al.
Published: (2018-09-01)